Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s12672-014-0171-4, but it redirected us to https://link.springer.com/article/10.1007/s12672-014-0171-4. The analysis below is for the second page.

Title[redir]:
Identification of Androgen Receptor Splice Variant Transcripts in Breast Cancer Cell Lines and Human Tissues | Discover Oncology
Description:
The androgen receptor (AR) is widely expressed in human tissues and has biological function in many male and female organs. In particular, the AR plays a critical role in the biology and pathology of the prostate gland. AR activity inhibits breast growth and has pleiotropic actions in breast cancer that are subtype-dependent. Expression of AR splice variants (ARVs) and their role in prostate carcinogenesis has been elucidated in recent studies. We hypothesised that ARVs are also expressed in breast cancers and other hormone sensitive tissues. Herein, the expression of five previously identified ARV transcripts with documented transcriptional capacity (AR-V1, -V3, -V4, -V7, and -V9) was examined in 6 breast (MFM223, MDA-MB-453, MDA-MB-231, ZR75.1, MCF-7, T47D), two prostate (VCaP, LNCaP), and one liver (HepG2) cancer cell lines, a human embryonic kidney cell line (HEK293), and a panel of RNAs representing 21 different human tissues. Four ARVs (V1, V3, V7, V9) were detected to some degree in almost all cell lines and tissues. In addition, four novel ARVs containing a cryptic exon 9 (CE9) were detected in MDA-MB-453 and VCaP cells. Sequencing of ARV amplicons revealed a single nucleotide substitution within CE3 in lung and placental tissue samples that could be translated as an Ile (ATT)>Val (GTT) substitution in the AR-V7 variant protein. Collectively, these data provides insight into the potential complexity of AR transcriptional splicing events in breast cancer cell lines and diverse human tissues, thereby establishing a rationale for further exploration of ARVs in breast cancer and other human pathologies.

Matching Content Categories {πŸ“š}

  • Education
  • Health & Fitness
  • Science

Content Management System {πŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We're unsure if the website is profiting.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {πŸ”}

cancer, arv, androgen, prostate, pubmed, receptor, breast, cell, arvs, article, human, google, scholar, tissues, cells, exon, cas, splice, lines, transcripts, expression, splicing, variant, mdamb, shown, variants, gene, cryptic, central, copy, target, expressed, rna, fig, exons, transcript, substitution, pcr, arfl, site, cterminal, numbers, research, vcap, single, including, liver, line, products, study,

Topics {βœ’οΈ}

ar-v7-specific c-terminal peptide c-terminal variant-specific peptides arv-specific c-terminal peptides c-terminal ligand-binding domain concomitant androgen-independent ar-signalling c-terminal unique peptide ar-v16-unique splicing junction ar-v15-specific splicing junction ar-v13-specific splicing junction c-terminal short peptide c-terminally adjacent residue n-terminal truncated variant n-terminal transactivation domain castration-resistant prostate cancer cell type-specific profiles arv/ar-fl expression ratios quantitative real-time pcr c-terminal peptides androgen deprivation therapy short-tandem repeat profiling ntd/dbd component attached full size image ntd/dbd domains encoded therapy-driven adaptive mechanisms x-linked reifenstein syndrome phenol red-free rpmi-1640 phenol red-free rpmi mda-mb-231 cell line mda-mb-453 cell line androgen-sensitive malignancies including conventional anti-androgenic drugs udp-glucuronosyltransferase 2b7 inhibit ar-fl activity including wild-type ar independently activate transcription arv/ar-fl ratio tissue-specific ar45 variant ligand binding domain androgen receptor variants dong gui hu ar-v7 variant protein fos-related antigen-2 alternative splice variants ar-fl copy numbers luminal androgen receptor androgen receptor splicing ar-fl transcripts compared similar ar-targeted therapies estrogen receptor alpha human androgen receptor

Questions {❓}

  • Guo Z, Qiu Y (2011) A new trick of an old molecule: androgen receptor splice variants taking the stage?
  • Hickey TE et al (2012) Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Identification of Androgen Receptor Splice Variant Transcripts in Breast Cancer Cell Lines and Human Tissues
         description:The androgen receptor (AR) is widely expressed in human tissues and has biological function in many male and female organs. In particular, the AR plays a critical role in the biology and pathology of the prostate gland. AR activity inhibits breast growth and has pleiotropic actions in breast cancer that are subtype-dependent. Expression of AR splice variants (ARVs) and their role in prostate carcinogenesis has been elucidated in recent studies. We hypothesised that ARVs are also expressed in breast cancers and other hormone sensitive tissues. Herein, the expression of five previously identified ARV transcripts with documented transcriptional capacity (AR-V1, -V3, -V4, -V7, and -V9) was examined in 6 breast (MFM223, MDA-MB-453, MDA-MB-231, ZR75.1, MCF-7, T47D), two prostate (VCaP, LNCaP), and one liver (HepG2) cancer cell lines, a human embryonic kidney cell line (HEK293), and a panel of RNAs representing 21 different human tissues. Four ARVs (V1, V3, V7, V9) were detected to some degree in almost all cell lines and tissues. In addition, four novel ARVs containing a cryptic exon 9 (CE9) were detected in MDA-MB-453 and VCaP cells. Sequencing of ARV amplicons revealed a single nucleotide substitution within CE3 in lung and placental tissue samples that could be translated as an Ile (ATT)>Val (GTT) substitution in the AR-V7 variant protein. Collectively, these data provides insight into the potential complexity of AR transcriptional splicing events in breast cancer cell lines and diverse human tissues, thereby establishing a rationale for further exploration of ARVs in breast cancer and other human pathologies.
         datePublished:2014-02-26T00:00:00Z
         dateModified:2014-02-26T00:00:00Z
         pageStart:61
         pageEnd:71
         sameAs:https://doi.org/10.1007/s12672-014-0171-4
         keywords:
            Androgen Receptor
            Breast Cancer Cell Line
            Androgen Deprivation Therapy
            LNCaP Cell
            Abiraterone
            Oncology
            Cancer Research
            Surgical Oncology
            Molecular Medicine
            Radiotherapy
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-014-0171-4/MediaObjects/12672_2014_171_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-014-0171-4/MediaObjects/12672_2014_171_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-014-0171-4/MediaObjects/12672_2014_171_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-014-0171-4/MediaObjects/12672_2014_171_Fig4_HTML.gif
         isPartOf:
            name:Hormones and Cancer
            issn:
               1868-8500
               1868-8497
            volumeNumber:5
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Dong Gui Hu
               affiliation:
                     name:Flinders University School of Medicine
                     address:
                        name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Theresa E. Hickey
               affiliation:
                     name:The University of Adelaide
                     address:
                        name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Connie Irvine
               affiliation:
                     name:The University of Adelaide
                     address:
                        name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dhilushi Dodampege Wijayakumara
               affiliation:
                     name:Flinders University School of Medicine
                     address:
                        name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lu Lu
               affiliation:
                     name:Flinders University School of Medicine
                     address:
                        name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wayne D. Tilley
               affiliation:
                     name:The University of Adelaide
                     address:
                        name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Luke A. Selth
               affiliation:
                     name:The University of Adelaide
                     address:
                        name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter I. Mackenzie
               affiliation:
                     name:Flinders University School of Medicine
                     address:
                        name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Identification of Androgen Receptor Splice Variant Transcripts in Breast Cancer Cell Lines and Human Tissues
      description:The androgen receptor (AR) is widely expressed in human tissues and has biological function in many male and female organs. In particular, the AR plays a critical role in the biology and pathology of the prostate gland. AR activity inhibits breast growth and has pleiotropic actions in breast cancer that are subtype-dependent. Expression of AR splice variants (ARVs) and their role in prostate carcinogenesis has been elucidated in recent studies. We hypothesised that ARVs are also expressed in breast cancers and other hormone sensitive tissues. Herein, the expression of five previously identified ARV transcripts with documented transcriptional capacity (AR-V1, -V3, -V4, -V7, and -V9) was examined in 6 breast (MFM223, MDA-MB-453, MDA-MB-231, ZR75.1, MCF-7, T47D), two prostate (VCaP, LNCaP), and one liver (HepG2) cancer cell lines, a human embryonic kidney cell line (HEK293), and a panel of RNAs representing 21 different human tissues. Four ARVs (V1, V3, V7, V9) were detected to some degree in almost all cell lines and tissues. In addition, four novel ARVs containing a cryptic exon 9 (CE9) were detected in MDA-MB-453 and VCaP cells. Sequencing of ARV amplicons revealed a single nucleotide substitution within CE3 in lung and placental tissue samples that could be translated as an Ile (ATT)>Val (GTT) substitution in the AR-V7 variant protein. Collectively, these data provides insight into the potential complexity of AR transcriptional splicing events in breast cancer cell lines and diverse human tissues, thereby establishing a rationale for further exploration of ARVs in breast cancer and other human pathologies.
      datePublished:2014-02-26T00:00:00Z
      dateModified:2014-02-26T00:00:00Z
      pageStart:61
      pageEnd:71
      sameAs:https://doi.org/10.1007/s12672-014-0171-4
      keywords:
         Androgen Receptor
         Breast Cancer Cell Line
         Androgen Deprivation Therapy
         LNCaP Cell
         Abiraterone
         Oncology
         Cancer Research
         Surgical Oncology
         Molecular Medicine
         Radiotherapy
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-014-0171-4/MediaObjects/12672_2014_171_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-014-0171-4/MediaObjects/12672_2014_171_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-014-0171-4/MediaObjects/12672_2014_171_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-014-0171-4/MediaObjects/12672_2014_171_Fig4_HTML.gif
      isPartOf:
         name:Hormones and Cancer
         issn:
            1868-8500
            1868-8497
         volumeNumber:5
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Dong Gui Hu
            affiliation:
                  name:Flinders University School of Medicine
                  address:
                     name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Theresa E. Hickey
            affiliation:
                  name:The University of Adelaide
                  address:
                     name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Connie Irvine
            affiliation:
                  name:The University of Adelaide
                  address:
                     name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dhilushi Dodampege Wijayakumara
            affiliation:
                  name:Flinders University School of Medicine
                  address:
                     name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lu Lu
            affiliation:
                  name:Flinders University School of Medicine
                  address:
                     name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wayne D. Tilley
            affiliation:
                  name:The University of Adelaide
                  address:
                     name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Luke A. Selth
            affiliation:
                  name:The University of Adelaide
                  address:
                     name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter I. Mackenzie
            affiliation:
                  name:Flinders University School of Medicine
                  address:
                     name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Hormones and Cancer
      issn:
         1868-8500
         1868-8497
      volumeNumber:5
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Flinders University School of Medicine
      address:
         name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
         type:PostalAddress
      name:The University of Adelaide
      address:
         name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
         type:PostalAddress
      name:The University of Adelaide
      address:
         name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
         type:PostalAddress
      name:Flinders University School of Medicine
      address:
         name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
         type:PostalAddress
      name:Flinders University School of Medicine
      address:
         name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
         type:PostalAddress
      name:The University of Adelaide
      address:
         name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
         type:PostalAddress
      name:The University of Adelaide
      address:
         name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
         type:PostalAddress
      name:Flinders University School of Medicine
      address:
         name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Dong Gui Hu
      affiliation:
            name:Flinders University School of Medicine
            address:
               name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Theresa E. Hickey
      affiliation:
            name:The University of Adelaide
            address:
               name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
               type:PostalAddress
            type:Organization
      name:Connie Irvine
      affiliation:
            name:The University of Adelaide
            address:
               name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
               type:PostalAddress
            type:Organization
      name:Dhilushi Dodampege Wijayakumara
      affiliation:
            name:Flinders University School of Medicine
            address:
               name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
               type:PostalAddress
            type:Organization
      name:Lu Lu
      affiliation:
            name:Flinders University School of Medicine
            address:
               name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
               type:PostalAddress
            type:Organization
      name:Wayne D. Tilley
      affiliation:
            name:The University of Adelaide
            address:
               name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Luke A. Selth
      affiliation:
            name:The University of Adelaide
            address:
               name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
               type:PostalAddress
            type:Organization
      name:Peter I. Mackenzie
      affiliation:
            name:Flinders University School of Medicine
            address:
               name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
      name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
      name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
      name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
      name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia
      name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
      name:Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, The University of Adelaide, Adelaide, Australia
      name:Department of Clinical Pharmacology, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Australia

External Links {πŸ”—}(299)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {πŸ“¦}

  • Crossref

4.67s.